United States · FDA National Drug Code directory
MELOXICAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61919-434_4d3b1449-8aaa-4caf-e063-6394a90a8a01
- Product NDC
- 61919-434
- Form
- TABLET
- Composition / generic term
- MELOXICAM
- Labeler
- Direct Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140101
- Source listing expiry
- 20271231
Source-listed ingredients
- MELOXICAM — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (61919-434-10) · 61919-434-10
- 20 TABLET in 1 BOTTLE (61919-434-20) · 61919-434-20
- 30 TABLET in 1 BOTTLE (61919-434-30) · 61919-434-30
- 60 TABLET in 1 BOTTLE (61919-434-60) · 61919-434-60
- 90 TABLET in 1 BOTTLE (61919-434-90) · 61919-434-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →